Importance of non-invasive liver fibrosis scores for mortality and complications development in individuals with type 2 diabetes

• Published in: Journal of diabetes and its complications Vol. 35; no. 5; p. 107879
• Main Authors: Leite, Nathalie C., Cardoso, Claudia R.L., Salles, Gil F.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.05.2021; Elsevier Limited
• Subjects: Age; Aged; Cardiovascular disease; Cardiovascular outcomes; Cohort analysis; Cohort Studies; Cohort study; Creatinine; Diabetes; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - mortality; Fatty liver; Female; Heart failure; Humans; Liver Cirrhosis - complications; Liver Cirrhosis - diagnosis; Liver diseases; Liver fibrosis scores; Male; Middle Aged; Mortality; Non-alcoholic fatty liver disease; Non-alcoholic Fatty Liver Disease - complications; Non-alcoholic Fatty Liver Disease - mortality; Patients; Peripheral neuropathy; Type 2 diabetes; Cardiovascular outcomes; Type 2 diabetes; Liver fibrosis scores; Non-alcoholic fatty liver disease; Cohort study; Mortality

To evaluate the non-alcoholic fatty liver disease (NAFLD) fibrosis score (NFS) and Fibrosis-4 score (FIB4) as predictors of complications development and mortality in a cohort of type 2 diabetes. 554 type 2 diabetic subjects had NFS and FIB4 calculated at baseline. Multivariate Cox and Poisson analy...